News

The pipeline of drugs in development in French biotechs saw a significant increase in 2008, but the funding climate may undermine this advance, says France Biotech.

Developing aerodynamic side skirts for truck trailers wasn’t exactly what Ephicas' founders had in mind when they started studying, but it has put them on the fast track.

President Obama’s move to focus on “science as economic saviour” may have stalled. But there is still optimism about the impact the new administration will have.

Cambridge spin-out CamSemi hopes to prosper during the global economic storm by riding the green wave. Its trump card: a new way of converting mains current to DC.